AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

IQVIA Holdings Inc.

$261.77 +$36.40 (+16.15%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$257.3
Day Range
$256.97$262.87
Year Range
$154.5$271.8
Market Cap
43.09B
AVG Volume
1.53M
Trailing/Forward PE
32.2/18.15
PEG ratio
2.87
Dividend Yield
-
Next Earnings Date
2026-11-03
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
02B4B6B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q24.37B
26 Q14.15B
25 Q44.36B
25 Q34.1B
25 Q24.02B
25 Q13.83B
24 Q43.96B
24 Q33.9B
24 Q23.81B
24 Q13.74B
Net Income (USD)
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2256M
26 Q1274M
25 Q4514M
25 Q3331M
25 Q2266M
25 Q1249M
24 Q4437M
24 Q3285M
24 Q2363M
24 Q1288M
Operating Income (USD)
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2506M
26 Q1514M
25 Q4732M
25 Q3553M
25 Q2506M
25 Q1496M
24 Q4626M
24 Q3550M
24 Q2548M
24 Q1506M
EBITDA (USD)
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2790M
26 Q1808M
25 Q41.05B
25 Q3883M
25 Q2781M
25 Q1753M
24 Q41.02B
24 Q3797M
24 Q2883M
24 Q1767M
Cash Flows (USD)
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2360M
26 Q1491M
25 Q4561M
25 Q31.2B
25 Q2292M
25 Q1426M
24 Q4721M
24 Q3571M
24 Q2445M
24 Q1377M
EPS (USD)
012324 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV EPS (USD) by quarter
PeriodEPS (USD)
26 Q21.53
26 Q11.61
25 Q42.99
25 Q31.93
25 Q21.54
25 Q11.4
24 Q42.42
24 Q31.55
24 Q21.97
24 Q11.56
Expenses (USD)
-500M0500M1BSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q2772M
26 Q1629M
25 Q4642M
25 Q3221M
25 Q2660M
25 Q1650M
24 Q4617M
24 Q3672M
24 Q2652M
24 Q1653M
Cash & Debt (USD)
05B10B15B20BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q22.08B
26 Q11.95B
25 Q42.14B
25 Q31.97B
25 Q22.19B
25 Q11.88B
24 Q41.84B
24 Q31.71B
24 Q21.68B
24 Q11.57B
Debt ratios
024624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV Debt ratios by quarter
PeriodDebt ratios
26 Q24.01
26 Q14.01
25 Q44.05
25 Q33.85
25 Q24.03
25 Q13.66
24 Q43.55
24 Q33.61
24 Q23.52
24 Q13.72
Margins
0%10%20%30%40%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV Margins by quarter
PeriodMargins
26 Q232.85%
26 Q132.64%
25 Q46.69%
25 Q333.49%
25 Q232.94%
25 Q133.9%
24 Q434.82%
24 Q335.37%
24 Q227.71%
24 Q134.6%
Return on Capital
0%2%4%6%8%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV Return on Capital by quarter
PeriodReturn on Capital
26 Q24.06%
26 Q14.32%
25 Q47.75%
25 Q35.26%
25 Q24.6%
25 Q14.16%
24 Q47.2%
24 Q34.09%
24 Q25.41%
24 Q14.54%
Shares Outstanding
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2167.2M
26 Q1168.4M
25 Q4170M
25 Q3170.2M
25 Q2171.8M
25 Q1175.7M
24 Q4178.9M
24 Q3182.1M
24 Q2182.2M
24 Q1181.9M
Book Value Per Share (USD)
01020304024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q237.69
26 Q137.7
25 Q439
25 Q336.94
25 Q233.68
25 Q134.06
24 Q433.91
24 Q338.26
24 Q236.85
24 Q134.88
Total Assets (USD)
010B20B30B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IQV Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q229.88B
26 Q129.68B
25 Q429.94B
25 Q328.73B
25 Q228.63B
25 Q127.32B
24 Q426.9B
24 Q327.18B
24 Q226.4B
24 Q126.57B
Employee Count
025K50K75K100K2016201720182019202020212022202320242025
IQV Employee Count by quarter
PeriodEmployee Count
202593K
202488K
202387K
202286K
202179K
202070K
201967K
201858K
201755K
201650K
PE Ratio
1520253035med 25.28Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IQV PE Ratio by quarter
PeriodPE Ratio
Sep 2631.83
Sep 2632.56
Aug 2631.83
Aug 2631.59
Aug 2628.78
Aug 2629.03
Jul 2628.58
Jul 2625.3
Jul 2625.08
Jul 2625.27
Jul 2625.17
Jun 2623.24
Jun 2620.4
Jun 2622.06
Jun 2622.31
May 2622.15
May 2620.41
May 2620.56
May 2621.73
May 2619.72
Apr 2620.29
Apr 2622.06
Apr 2620.92
Apr 2621.66
Mar 2620.48
Mar 2620.76
Mar 2620.59
Mar 2621.81
Feb 2622.35
Feb 2620.7
Feb 2622.15
Feb 2624.87
Jan 2630.53
Jan 2631.22
Jan 2631.53
Jan 2632.16
Jan 2629.9
Dec 2530.1
Dec 2529.28
Dec 2529.48
Dec 2529.96
Nov 2530.51
Nov 2529.83
Nov 2529.27
Nov 2527.92
Oct 2528.72
Oct 2530.63
Oct 2528.41
Oct 2527.52
Oct 2528.7
Sep 2524.94
Sep 2526
Sep 2526
Sep 2526.07
Aug 2526.5
Aug 2526.55
Aug 2526.54
Aug 2524.98
Aug 2525.34
Jul 2527.66
Jul 2521.16
Jul 2521.44
Jul 2521.63
Jun 2520.74
Jun 2520.38
Jun 2520.66
Jun 2520.06
May 2518.48
May 2518.04
May 2518.81
May 2519.62
May 2520
Apr 2519.58
Apr 2518.75
Apr 2518.96
Apr 2520.16
Mar 2523.11
Mar 2524.22
Mar 2524.13
Mar 2524.97
Feb 2524.6
Feb 2524.89
Feb 2525.2
Feb 2526.98
Jan 2526.1
Jan 2526.48
Jan 2525.58
Jan 2526.35
Jan 2525.58
Dec 2425.84
Dec 2425.57
Dec 2425.8
Dec 2426.26
Nov 2426.03
Nov 2426.16
Nov 2424.97
Nov 2428.41
Nov 2427.11
Oct 2427.48
Oct 2430.31
Free Cash Flow Yield
4%6%8%10%med 6.79%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IQV Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 265.97%
Sep 265.84%
Aug 265.97%
Aug 266.01%
Aug 266.6%
Aug 266.55%
Jul 266.65%
Jul 267.26%
Jul 267.33%
Jul 267.27%
Jul 267.3%
Jun 267.91%
Jun 269.01%
Jun 268.33%
Jun 268.24%
May 268.29%
May 269%
May 268.94%
May 268.46%
May 269.25%
Apr 268.99%
Apr 268.27%
Apr 268.72%
Apr 268.42%
Mar 268.9%
Mar 268.78%
Mar 268.86%
Mar 268.36%
Feb 268.16%
Feb 268.81%
Feb 269.29%
Feb 268.27%
Jan 266.74%
Jan 266.59%
Jan 266.53%
Jan 266.4%
Jan 266.88%
Dec 256.84%
Dec 257.03%
Dec 256.98%
Dec 256.87%
Nov 256.74%
Nov 256.9%
Nov 257.03%
Nov 257.37%
Oct 257.17%
Oct 255.31%
Oct 255.72%
Oct 255.9%
Oct 255.66%
Sep 256.52%
Sep 256.25%
Sep 256.25%
Sep 256.23%
Aug 256.13%
Aug 256.12%
Aug 256.12%
Aug 256.5%
Aug 256.41%
Jul 255.87%
Jul 257.66%
Jul 257.56%
Jul 257.5%
Jun 257.82%
Jun 257.96%
Jun 257.85%
Jun 258.08%
May 258.77%
May 258.99%
May 258.62%
May 258.26%
May 257.7%
Apr 257.86%
Apr 258.21%
Apr 258.12%
Apr 257.64%
Mar 256.66%
Mar 256.36%
Mar 256.38%
Mar 256.17%
Feb 256.26%
Feb 256.19%
Feb 256.11%
Feb 255.17%
Jan 255.35%
Jan 255.27%
Jan 255.46%
Jan 255.3%
Jan 255.46%
Dec 245.4%
Dec 245.46%
Dec 245.41%
Dec 245.31%
Nov 245.36%
Nov 245.34%
Nov 245.59%
Nov 244.91%
Nov 245.15%
Oct 244.67%
Oct 244.24%
Price to Sales
1.522.53med 2.11Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IQV Price to Sales by quarter
PeriodPrice to Sales
Sep 262.58
Sep 262.64
Aug 262.58
Aug 262.56
Aug 262.33
Aug 262.35
Jul 262.31
Jul 262.11
Jul 262.09
Jul 262.1
Jul 262.1
Jun 261.94
Jun 261.7
Jun 261.84
Jun 261.86
May 261.84
May 261.7
May 261.71
May 261.81
May 261.64
Apr 261.69
Apr 261.84
Apr 261.74
Apr 261.81
Mar 261.71
Mar 261.73
Mar 261.72
Mar 261.82
Feb 261.86
Feb 261.73
Feb 261.79
Feb 262.01
Jan 262.46
Jan 262.52
Jan 262.54
Jan 262.59
Jan 262.41
Dec 252.43
Dec 252.36
Dec 252.38
Dec 252.42
Nov 252.46
Nov 252.41
Nov 252.36
Nov 252.25
Oct 252.32
Oct 252.41
Oct 252.24
Oct 252.17
Oct 252.26
Sep 251.96
Sep 252.05
Sep 252.05
Sep 252.05
Aug 252.09
Aug 252.09
Aug 252.09
Aug 251.97
Aug 252
Jul 252.18
Jul 251.82
Jul 251.85
Jul 251.86
Jun 251.79
Jun 251.75
Jun 251.78
Jun 251.73
May 251.59
May 251.55
May 251.62
May 251.69
May 251.78
Apr 251.75
Apr 251.67
Apr 251.69
Apr 251.8
Mar 252.06
Mar 252.16
Mar 252.15
Mar 252.23
Feb 252.19
Feb 252.22
Feb 252.25
Feb 252.47
Jan 252.39
Jan 252.43
Jan 252.35
Jan 252.42
Jan 252.35
Dec 242.37
Dec 242.35
Dec 242.37
Dec 242.41
Nov 242.39
Nov 242.4
Nov 242.29
Nov 242.61
Nov 242.49
Oct 242.58
Oct 242.85
EV/EBITDA
1012141618med 13.74Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IQV EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2616.42
Sep 2616.7
Aug 2616.42
Aug 2616.33
Aug 2615.23
Aug 2615.33
Jul 2615.15
Jul 2613.97
Jul 2613.88
Jul 2613.96
Jul 2613.92
Jun 2613.16
Jun 2612.04
Jun 2612.7
Jun 2612.79
May 2612.73
May 2612.05
May 2612.11
May 2612.56
May 2611.79
Apr 2612.02
Apr 2612.71
Apr 2612.26
Apr 2612.55
Mar 2612.09
Mar 2612.2
Mar 2612.13
Mar 2612.61
Feb 2612.83
Feb 2612.18
Feb 2612.12
Feb 2613.14
Jan 2615.25
Jan 2615.51
Jan 2615.62
Jan 2615.86
Jan 2615.01
Dec 2515.09
Dec 2514.78
Dec 2514.86
Dec 2515.04
Nov 2515.24
Nov 2514.99
Nov 2514.78
Nov 2514.28
Oct 2514.57
Oct 2515.35
Oct 2514.53
Oct 2514.2
Oct 2514.63
Sep 2513.25
Sep 2513.64
Sep 2513.64
Sep 2513.66
Aug 2513.82
Aug 2513.84
Aug 2513.84
Aug 2513.26
Aug 2513.39
Jul 2514.25
Jul 2511.84
Jul 2511.95
Jul 2512.02
Jun 2511.68
Jun 2511.54
Jun 2511.65
Jun 2511.42
May 2510.8
May 2510.64
May 2510.93
May 2511.25
May 2511.48
Apr 2511.31
Apr 2510.98
Apr 2511.07
Apr 2511.54
Mar 2512.71
Mar 2513.15
Mar 2513.12
Mar 2513.45
Feb 2513.3
Feb 2513.42
Feb 2513.54
Feb 2515.04
Jan 2514.67
Jan 2514.83
Jan 2514.45
Jan 2514.77
Jan 2514.45
Dec 2414.56
Dec 2414.44
Dec 2414.54
Dec 2414.74
Nov 2414.64
Nov 2414.69
Nov 2414.19
Nov 2415.65
Nov 2415.1
Oct 2415.2
Oct 2416.4
Price/Operating Cashflow
7.51012.51517.520med 12.57Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IQV Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2615.53
Sep 2615.88
Aug 2615.52
Aug 2615.41
Aug 2614.04
Aug 2614.16
Jul 2613.94
Jul 2612.96
Jul 2612.85
Jul 2612.94
Jul 2612.89
Jun 2611.9
Jun 2610.45
Jun 2611.3
Jun 2611.42
May 2611.35
May 2610.46
May 2610.53
May 2611.13
May 2610.11
Apr 2610.39
Apr 2611.3
Apr 2610.72
Apr 2611.1
Mar 2610.5
Mar 2610.64
Mar 2610.55
Mar 2611.18
Feb 2611.45
Feb 2610.61
Feb 2610.13
Feb 2611.38
Jan 2613.97
Jan 2614.28
Jan 2614.43
Jan 2614.71
Jan 2613.68
Dec 2513.77
Dec 2513.4
Dec 2513.49
Dec 2513.71
Nov 2513.96
Nov 2513.65
Nov 2513.39
Nov 2512.77
Oct 2513.14
Oct 2514.48
Oct 2513.43
Oct 2513.01
Oct 2513.56
Sep 2511.79
Sep 2512.29
Sep 2512.29
Sep 2512.32
Aug 2512.53
Aug 2512.55
Aug 2512.54
Aug 2511.81
Aug 2511.98
Jul 2513.08
Jul 2510.22
Jul 2510.36
Jul 2510.45
Jun 2510.02
Jun 259.84
Jun 259.98
Jun 259.69
May 258.93
May 258.72
May 259.09
May 259.48
May 2510.11
Apr 259.9
Apr 259.48
Apr 259.59
Apr 2510.19
Mar 2511.68
Mar 2512.24
Mar 2512.2
Mar 2512.62
Feb 2512.44
Feb 2512.58
Feb 2512.74
Feb 2514.7
Jan 2514.22
Jan 2514.43
Jan 2513.94
Jan 2514.36
Jan 2513.94
Dec 2414.08
Dec 2413.93
Dec 2414.06
Dec 2414.31
Nov 2414.19
Nov 2414.26
Nov 2413.61
Nov 2415.49
Nov 2414.77
Oct 2416.03
Oct 2417.67
Price to Book
45678med 5.34Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IQV Price to Book by quarter
PeriodPrice to Book
Sep 266.95
Sep 267.11
Aug 266.95
Aug 266.89
Aug 266.28
Aug 266.33
Jul 266.24
Jul 265.52
Jul 265.47
Jul 265.51
Jul 265.49
Jun 265.07
Jun 264.45
Jun 264.81
Jun 264.87
May 264.83
May 264.45
May 264.49
May 264.74
May 264.05
Apr 264.16
Apr 264.52
Apr 264.29
Apr 264.44
Mar 264.2
Mar 264.26
Mar 264.22
Mar 264.47
Feb 264.58
Feb 264.25
Feb 264.52
Feb 265.07
Jan 266.23
Jan 266.37
Jan 266.43
Jan 266.56
Jan 266.1
Dec 256.14
Dec 255.97
Dec 256.02
Dec 256.11
Nov 256.23
Nov 256.09
Nov 255.97
Nov 255.7
Oct 255.86
Oct 256.55
Oct 256.07
Oct 255.88
Oct 256.14
Sep 255.33
Sep 255.56
Sep 255.56
Sep 255.57
Aug 255.67
Aug 255.68
Aug 255.67
Aug 255.34
Aug 255.42
Jul 255.91
Jul 254.72
Jul 254.78
Jul 254.82
Jun 254.62
Jun 254.54
Jun 254.61
Jun 254.47
May 254.12
May 254.02
May 254.19
May 254.37
May 254.53
Apr 254.43
Apr 254.24
Apr 254.29
Apr 254.56
Mar 255.23
Mar 255.48
Mar 255.46
Mar 255.65
Feb 255.57
Feb 255.63
Feb 255.7
Feb 255.44
Jan 255.26
Jan 255.34
Jan 255.16
Jan 255.31
Jan 255.16
Dec 245.21
Dec 245.16
Dec 245.2
Dec 245.3
Nov 245.25
Nov 245.28
Nov 245.04
Nov 245.73
Nov 245.47
Oct 245.82
Oct 246.42
IQVIA Holdings Inc.
IQV
Stockpicker

Video analysis: IQV

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: IQV

Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term

zacks.com · 11 Sep 2026

Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Arizona State Retirement System Buys 2,372 Shares of IQVIA Holdings Inc. $IQV

defenseworld.net · 10 Sep 2026

Arizona State Retirement System Buys 2,372 Shares of IQVIA Holdings Inc. $IQV

Arizona State Retirement System lifted its stake in IQVIA Holdings Inc. (NYSE: IQV) by 5.1% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 48,655 shares of the medical research company's stock after purchasing an additional 2,372 shares during the quarter. Arizona

IQVIA Announces Pricing of Senior Notes

businesswire.com · 9 Sep 2026

IQVIA Announces Pricing of Senior Notes

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2034 (the “Notes”). The proceeds from the Notes offering will be used to redeem in full the Issuer's Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer's revolving credit facility and to pay fees and e.

IQVIA Announces Offering of Senior Notes

gurufocus.com · 9 Sep 2026

IQVIA Announces Offering of Senior Notes

IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $2,000,000,000 th

IQVIA Announces Offering of Senior Notes

businesswire.com · 9 Sep 2026

IQVIA Announces Offering of Senior Notes

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $2,000,000,000 through an offering of senior notes due 2034 (the “Notes”). The proceeds from the Notes offering will be used to redeem in full the Issuer's Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer's revolving credit facility and to pay fees and expenses relate.

B. Metzler seel. Sohn & Co. AG Lowers Holdings in IQVIA Holdings Inc. $IQV

defenseworld.net · 4 Sep 2026

B. Metzler seel. Sohn & Co. AG Lowers Holdings in IQVIA Holdings Inc. $IQV

B. Metzler seel. Sohn and Co. AG cut its holdings in IQVIA Holdings Inc. (NYSE: IQV) by 28.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 24,610 shares of the medical research company's stock after selling 9,713 shares

IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster

businesswire.com · 3 Sep 2026

IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to patients up to two years faster. Traditional approaches in clinical development no longer keep pace with increasing trial complexity. IQVIA Predictive Clinical.

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

businesswire.com · 27 Aug 2026

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial executio.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.